Stenoparib Receives FDA Fast Track Designation in Advanced Ovarian Cancer
The novel treatment was evaluated in a phase 2 trial and saw a clinical benefit in patients with advanced ovarian cancer.
Previous Post
#VisualAbstract: Once-weekly Semaglutide Reduces Body Weight in People with Obesity
Next Post
Philips Unveils Cardiovascular Ultrasound Software Transcend Plus
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago